Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Meier

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
American Journal of Obstetrics and Gynecology|January 27, 2005
Age-specific risk of fetal loss observed in a second trimester serum screening populationPhilip R Wyatt, Titus Owolabi, Chris Meier, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2008
Bioreversible protection of nucleoside diphosphatesHenning Jacob Jessen, Tilmann Schulz, Jan Balzarini, et al.
Prenatal Diagnosis|June 19, 2003
Accuracy of trisomy 18 screening using the second-trimester triple testChris Meier, Tianhua Huang, Philip R Wyatt, et al.
Angewandte Chemie (International Ed. in English)|May 8, 2020
Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse TranscriptaseChenglong Zhao, Stefan Weber, Dominique Schols, et al.
Mini Reviews in Medicinal Chemistry|May 12, 2004
"Lock-in"-cycloSal-pronucleotides - a new generation of chemical Trojan Horses?Chris Meier, Manuel F H Ruppel, Dalibor Vukadinovic, et al.
Obstetrics and Gynecology|June 12, 2003
The implications of a false positive second-trimester serum screen for Down syndromeAnne M Summers, Tianhua Huang, Chris Meier, et al.
Journal of Medicinal Chemistry|May 14, 2004
Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationshipChris Meier, Christian Ducho, Ulf Görbig, et al.
Clinical Chemistry|March 20, 2002
Accuracy of expected risk of Down syndrome using the second-trimester triple testChris Meier, Tianhua Huang, Philip R Wyatt, et al.
Chemmedchem|October 22, 2020
γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIVChenglong Zhao, Xiao Jia, Dominique Schols, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Synthesis and analysis of potential α1,3-fucosyltransferase inhibitorsKatrin Seelhorst, Tomas Piernitzki, Nathalie Lunau, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
American Journal of Obstetrics and Gynecology|January 27, 2005
Age-specific risk of fetal loss observed in a second trimester serum screening populationPhilip R Wyatt, Titus Owolabi, Chris Meier, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2008
Bioreversible protection of nucleoside diphosphatesHenning Jacob Jessen, Tilmann Schulz, Jan Balzarini, et al.
Prenatal Diagnosis|June 19, 2003
Accuracy of trisomy 18 screening using the second-trimester triple testChris Meier, Tianhua Huang, Philip R Wyatt, et al.
Angewandte Chemie (International Ed. in English)|May 8, 2020
Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse TranscriptaseChenglong Zhao, Stefan Weber, Dominique Schols, et al.
Mini Reviews in Medicinal Chemistry|May 12, 2004
"Lock-in"-cycloSal-pronucleotides - a new generation of chemical Trojan Horses?Chris Meier, Manuel F H Ruppel, Dalibor Vukadinovic, et al.
Obstetrics and Gynecology|June 12, 2003
The implications of a false positive second-trimester serum screen for Down syndromeAnne M Summers, Tianhua Huang, Chris Meier, et al.
Journal of Medicinal Chemistry|May 14, 2004
Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationshipChris Meier, Christian Ducho, Ulf Görbig, et al.
Clinical Chemistry|March 20, 2002
Accuracy of expected risk of Down syndrome using the second-trimester triple testChris Meier, Tianhua Huang, Philip R Wyatt, et al.
Chemmedchem|October 22, 2020
γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIVChenglong Zhao, Xiao Jia, Dominique Schols, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Synthesis and analysis of potential α1,3-fucosyltransferase inhibitorsKatrin Seelhorst, Tomas Piernitzki, Nathalie Lunau, et al.
Pageof 14